PATENT CLAIM ANALYSIS

Application Number: 16109199
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-06
Patent Classification: ["514", "352000"]

Abstract:
Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.

Claim (Index 26):
A method for treating a subject with melanoma, thyroid cancer, or colorectal cancer, said method comprising administering to the subject:\n an effective amount of a compound of formula (Ia): or a pharmaceutically acceptable salt thereof, wherein: L 1  is a bond; each R 1  is \u2014N(R 5 )\u2014C(X)\u2014R 7 , lower alkyl, or optionally substituted heteroaryl; R 2  is hydrogen or halogen; R 4  is hydrogen; R 3  is optionally substituted lower alkyl or optionally substituted aryl; m is 0, 1, 2, or 3; Ar is a monocyclic heteroaryl containing 5 to 6 atoms wherein at least one atom is nitrogen; R 5  is hydrogen; X is O; and R 7  is lower alkyl.

Metadata:
- Claim Count in Document: 155.0
- Percentile: 96.0
- Lexical Diversity: 1.16
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15048851', '15260042', '14514232', '12467208', '11960590']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7667480070382747
- 35 USC 102 Novelty (BERT): 0.5775824241774884
- Combined Prediction Score: 0.7478314487521961
- Mean Citation Score: 364.02459
- Max Citation Score: 421.83148
- Similarity Product: 307.0230864828587

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test